Last update 08 May 2025

TLR4 x NGFB

Basic Info

Related Targets
TLR4NGFB

Related

1
Drugs associated with TLR4 x NGFB
Rimtoregtide
Target
NGFB x TLR4
Mechanism
NGFB stimulants [+1]
Active Org.
Nanjing Medical UniversityNanjing Medical University [+2]
Originator Org.
Hightide Therapeutics, Inc.Hightide Therapeutics, Inc.
Active Indication
Hepatitis, Alcoholic [+2]
Inactive Indication
Diabetes Mellitus, Type 2
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with TLR4 x NGFB
NCT02538848
/ CompletedPhase 1
A First in Human, Randomized, Double-Blind Study to Assess Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Effects of HTD4010 in Healthy Participants
100 Clinical Results associated with TLR4 x NGFB
Login to view more data
100 Translational Medicine associated with TLR4 x NGFB
Login to view more data
0 Patents (Medical) associated with TLR4 x NGFB
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free